-
Allergen Guides FY 2011 $3.56-3.62 vs. $3.61 Estimate; Revenues $5050-5250M (AGN)
Wednesday, May 4, 2011 - 9:03am | 20Allergen (NYSE: AGN) Guides FY 2011 $3.56-3.62 vs. $3.61 Estimate; Guides Revenues $5050-5250M
-
Allergan Reports EPS of $0.77 vs. $0.74 Estimate; Revenues $1.27B vs. $1.22B Estimate (AGN)
Wednesday, May 4, 2011 - 9:02am | 21Allergan (NYSE: AGN) Reports EPS of $0.77 vs. $0.74 Estimate; Revenues $1.27B vs. $1.22B Estimate
-
Goldman Sachs Neutral On Tenneco Inc. (TEN)
Wednesday, May 4, 2011 - 8:41am | 219Goldman Sachs has a Neutral rating and a $48 price target on shares of Tenneco Inc. (NYSE: TEN) after it reported earnings. In anote to clients, Goldman writes, "Tenneco reported strong 1Q results helped by both revenue and margins that came in ahead of our expectations. Our upwardly revised...
-
Global Hunter Securities Raises PT On MDVN To $30
Wednesday, May 4, 2011 - 8:26am | 277Global Hunter Securities has raised its price target from $24 to $30 on Medivation (NASDAQ: MDVN) in its preview of Q1:11 results which are to be released after the market close on Friday. In the report, Global Hunter Securities writes, “We believe the focus of the earnings call will be on an...
-
Benzinga's Top Upgrades (SNY, FSLR, VCLK, BLK)
Wednesday, May 4, 2011 - 8:08am | 131Bank of America Merrill Lynch upgraded Sanofi-Aventis SA (NYSE: SNY) from “neutral” to “buy.” SNY's shares closed at $40.05 yesterday. Sanofi-Aventis' trailing-twelve-month operating margin is 24.08%. Auriga upgraded First Solar Inc (NASDAQ: FSLR) from “hold” to “buy.” FSLR's shares closed at $134...
-
ULURU Announces the Filing of a 510(k) Application for Altrazeal Collagen
Wednesday, May 4, 2011 - 8:07am | 36ULURU Inc. (NYSE: ULU) announced today that it has filed a 510(k) application with the U.S. Food and Drug Administration to obtain marketing authorization for Altrazeal® Collagen.
-
Ironwood and Forest to Present Linaclotide Results from Phase 3 Trials in Patients with Irritable Bowel Syndrome with Constipation (IRWD, FRX)
Wednesday, May 4, 2011 - 8:04am | 95Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) and Forest Laboratories, Inc. (NYSE: FRX) today announced they will be presenting linaclotide results from Phase 3 clinical trials in patients with irritable bowel syndrome with constipation during the 2011 Digestive Disease Week annual meeting that...
-
Deutsche Bank Maintains Buy Rating On MAPP After Unexpected Q1 Profit
Wednesday, May 4, 2011 - 7:33am | 87In a recent report, Deutsche Bank maintained a buy rating on MAP Pharmaceuticals (NASDAQ: MAPP) and reported on the unexpected profit resulting in a $0.56 EPS versus Deutsche Bank's previous estimate of $0.36. In the report, Deutsche Bank said, "Based upon a significant unmet need among migraine...
-
CEOWORLD Most Actives Top Healthcare stocks picks on 5/4/11- GENE, SPPI, AMRI, GTXI, AFFX,KV.A, SCLN, CBM, CERS, CEPH, TEVA, THC, JNJ
Wednesday, May 4, 2011 - 6:59am | 1424Gainers (% price change): Genetic Tech. Ltd. (ADR) (GENE) engaged in a diagnostic product business is trading at a price of $8.18, a dramatic change of +2.41 (41.77%) from its previous day's close. Currently, the company has a Market capitalization (total value of a company in the stock market)...
-
Top 4 Small-Cap Stocks In The Drugs-Generic Industry With The Highest Revenue (PRX, CPD, HITK, AKRX)
Wednesday, May 4, 2011 - 5:17am | 133Below are the top small-cap drugs-generic stocks on the NYSE, the NASDAQ and the AMEX in terms of revenue. The trailing-twelve-month revenue at Pharmaceutical Companies (NYSE: PRX) is $1.01 billion. PRX's ROE for the same period is 16.46%. The trailing-twelve-month revenue at Caraco...
-
Earnings Scheduled For May 4 (PCG, WFMI, TWX, BUD, MET, MGM, ERTS, AOL, RIG, AGN, JDSU, NWSA, TSLA, ACE, GG, CSC, K, KKR, BMC, MMC, PRU, RRD, VG)
Wednesday, May 4, 2011 - 2:20am | 597PG&E Corp (NYSE: PCG) is expected to post its Q1 earnings at $0.81 per share on revenue of $3.59 billion. Whole Foods Market Inc (NASDAQ: WFMI) is estimated to post its Q2 EPS at $0.46 on revenue of $2.37 billion. Time Warner Inc (NYSE: TWX) is projected to report its Q1 EPS at $0.57 on...
-
Trading Volatility 05-03-2011
Tuesday, May 3, 2011 - 6:41pm | 839Cusick's Corner With the market teetering on a potential short-term pullback and volatility on the move, strategists may want to brush up on in-the-money calendar spreads. If you are short-term bearish and long-term bullish, selling the front month in-the-money option against the longer term long...
-
Fast Money Picks For May 4th (TIP, ABT, AAPL, JPM)
Tuesday, May 3, 2011 - 6:38pm | 183CNBC Fast Money's Brian Kelly said that investors should buy iShares Barclays TIPS Bond Fund (ETF) (AMEX: TIP) on Wednesday. iShares Barclays TIPS Bond Fund (ETF) (TIP) gained 0.16%, and it closed at $110.93. Guy Adami likes Abbott Laboratories (NYSE: ABT), and wants to buy it tomorrow. Abbott...
-
Defense, Defense 05-03-2011
Tuesday, May 3, 2011 - 3:40pm | 1010Cusick's Corner Defense is in play. The VIX continues higher, 3 up days in a row, Financials (XLF) and Tech (QQQQ) lag and are now well behind Consumer Staples (XLP) and Healthcare (XLV). There's been a rush to Consumer Staples like toothpaste, beverages, soap, and Drugs (not the illegal kind!),...
-
PRISTIQExtended Release Tablets Shown To Significantly Reduce Number And Severity Of Moderate-To-Severe Hot Flashes Associated With Menopause (PFE)
Tuesday, May 3, 2011 - 10:31am | 64Pfizer Inc. (NYSE: PFE) today announced results from a Phase 3 12-week efficacy sub-study, which found that PRISTIQ, a serotonin-norepinephrine reuptake inhibitor, significantly reduced the number and severity of moderate-to-severe hot flashes in postmenopausal women. The data were presented at the...